Fibrinogen and prothrombin binding is enhanced to the Pro33 isoform of purified integrin αIIbβ3 [8]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 4, 2006, Pages 905-906

  Vijayan, K V ^a   Liu, Y ^a   Souza, S ^a   Thiagarajan, P ^a   Bray, Paul F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B BETA3 INTEGRIN; FIBRINOGEN; GLYCOPROTEIN; ISOPROTEIN; PROLINE; PROTHROMBIN; UNCLASSIFIED DRUG;

AGE; AMINO ACID SUBSTITUTION; CELL ADHESION; CIGARETTE SMOKING; GENDER; HUMAN; IN VITRO STUDY; LETTER; LIVING DONOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

BLOOD PLATELETS; FIBRINOGEN; HUMANS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROLINE; PROTEIN BINDING; PROTEIN ISOFORMS; PROTHROMBIN;

EID: 33644986664     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01850.x     Document Type: Letter

References (10)

1. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
2. A polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013-8.
3. A2 polymorphism: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-7.
4. 3-integrins in platelets. Blood 2001; 97: 3093-9.
5. 3 subunit (glycoprotein IIIa). Br J Haematol 2000; 110: 911-8.
6. 3 (glycoprotein Iib-IIIa) from human platelets. J Tissue Cult Methods 1999; 16: 249-53
7. 3 enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793-802.
8. 3 binds prothrombin and influences its activation. J Biol Chem 1997; 272: 27183-8.
9. 3 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 2001; 104: 2666-72.
10. A2. Tissue Antigens 1995; 46: 374-81.